Polarityte, Inc.
PTEDelisted Jul 10, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001076682
Polarityte, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jan 30, 2023; 46 institutions reported holding it in 13F filings for Q1 2022, worth $4.01M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Polarityte, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 50 | 49 | −1 |
| Shares | 11.1M | 10.8M | −357.7K (−3.2%) |
| Value | $11.1M | $6.92M | −$4.23M (−37.9%) |
New holders (7)
Institutions that held Polarityte, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 142,847 | $92.0K | 0.01% |
| Renaissance Technologies LLC | 35,600 | $23.0K | 0.00% |
| HRT Financial LP | 27,050 | $17.0K | 0.00% |
| Newman Dignan & Sheerar, Inc. | 20,803 | $13.0K | 0.00% |
| Susquehanna International Group, LLP | 11,091 | $7.00K | 0.00% |
| American Portfolios Advisors | 3 | $2 | 0.00% |
| Meridian Wealth Partners, LLC | 185 | $0 | 0.00% |
Sold out (8)
Institutions that held Polarityte, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Levin Capital Strategies, L.P. | 70,000 | $71.0K |
| XTX Topco Ltd | 59,633 | $61.0K |
| Charles Schwab Investment Management Inc | 44,182 | $46.0K |
| Two Sigma Advisers, LP | 27,129 | $28.0K |
| Pinz Capital Management, LP | 18,500 | $19.0K |
| UBS Group AG | 10,100 | $10.0K |
| Cubist Systematic Strategies, LLC | 930 | $1.00K |
| Captrust Financial Advisors | 1 | $0 |